Nemes Rush Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.48M | Buy |
22,350
+21,612
| +2,928% | +$2.4M | 0.27% | 66 |
|
|
2025
Q1 | $82.7K | Hold |
738
| – | – | 0.01% | 268 |
|
|
2024
Q4 | $68.2K | Sell |
738
-5,858
| -89% | -$541K | 0.01% | 272 |
|
|
2024
Q3 | $483K | Buy |
6,596
+5,715
| +649% | +$419K | 0.07% | 117 |
|
|
2024
Q2 | $60.4K | Sell |
881
-5,740
| -87% | -$394K | 0.01% | 247 |
|
|
2024
Q1 | $485K | Sell |
6,621
-23,220
| -78% | -$1.7M | 0.07% | 117 |
|
|
2023
Q4 | $2.42M | Sell |
29,841
-230
| -0.8% | -$18.6K | 0.39% | 55 |
|
|
2023
Q3 | $2.25M | Sell |
30,071
-290
| -1% | -$21.7K | 0.41% | 56 |
|
|
2023
Q2 | $2.34M | Buy |
+30,361
| New | +$2.34M | 0.41% | 56 |
|